Your story could help someone else make a more informed decision or simply feel a little less alone
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
Navigating this conundrum requires a strategic approach to balance costs and employee health benefits
Among non-elderly adults with ESI (estimated to be 116.8 million from NHIS), 42%, or 49.3 million people, are clinically eligible for GLP-1 drugs
Even temporary weight loss produces lasting health benefits including improved cardiovascular risk markers, reduced joint stress, improved sleep apnea, and better metabolic function
Ozempic is especially helpful for people with type 2 diabetes